PA
Parallel Advisors’s Corcept Therapeutics CORT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284M | Sell |
3,871,123
-101,293
| -3% | -$7.43M | 5.68% | 3 |
|
|
2025
Q1 | $220M | Buy |
3,972,416
+142,784
| +4% | +$7.89M | 4.95% | 3 |
|
|
2024
Q4 | $193M | Buy |
3,829,632
+15,908
| +0.4% | +$802K | 4.34% | 4 |
|
|
2024
Q3 | $176M | Sell |
3,813,724
-2,036
| -0.1% | -$94.2K | 4.15% | 4 |
|
|
2024
Q2 | $124M | Buy |
3,815,760
+83
| +0% | +$2.7K | 3.18% | 5 |
|
|
2024
Q1 | $96.1M | Buy |
3,815,677
+47,432
| +1% | +$1.19M | 2.6% | 5 |
|
|
2023
Q4 | $122M | Buy |
3,768,245
+44,762
| +1% | +$1.45M | 3.63% | 4 |
|
|
2023
Q3 | $101M | Sell |
3,723,483
-3,082
| -0.1% | -$84K | 3.38% | 3 |
|
|
2023
Q2 | $82.9M | Buy |
3,726,565
+1,992
| +0.1% | +$44.3K | 2.67% | 4 |
|
|
2023
Q1 | $80.7M | Sell |
3,724,573
-91
| -0% | -$1.97K | 2.72% | 4 |
|
|
2022
Q4 | $75.6M | Sell |
3,724,664
-44,791
| -1% | -$910K | 3.28% | 5 |
|
|
2022
Q3 | $96.6M | Buy |
3,769,455
+1,051,127
| +39% | +$27M | 4.45% | 3 |
|
|
2022
Q2 | $64.6M | Buy |
2,718,328
+774,009
| +40% | +$18.4M | 2.97% | 5 |
|
|
2022
Q1 | $47M | Buy |
1,944,319
+140,937
| +8% | +$3.41M | 1.87% | 9 |
|
|
2021
Q4 | $35.7M | Buy |
1,803,382
+76,474
| +4% | +$1.51M | 1.33% | 11 |
|
|
2021
Q3 | $34M | Buy |
1,726,908
+52,551
| +3% | +$1.03M | 1.37% | 10 |
|
|
2021
Q2 | $36.8M | Buy |
1,674,357
+110,383
| +7% | +$2.43M | 1.56% | 11 |
|
|
2021
Q1 | $37.2M | Buy |
1,563,974
+15,358
| +1% | +$365K | 1.76% | 10 |
|
|
2020
Q4 | $40.5M | Buy |
1,548,616
+253,712
| +20% | +$6.64M | 2.2% | 7 |
|
|
2020
Q3 | $22.5M | Sell |
1,294,904
-109,541
| -8% | -$1.91M | 1.39% | 15 |
|
|
2020
Q2 | $23.6M | Sell |
1,404,445
-1,450
| -0.1% | -$24.4K | 1.54% | 12 |
|
|
2020
Q1 | $16.7M | Hold |
1,405,895
| – | – | 1.35% | 13 |
|
|
2019
Q4 | $17M | Buy |
1,405,895
+128,044
| +10% | +$1.55M | 1.28% | 14 |
|
|
2019
Q3 | $18.1M | Buy |
1,277,851
+1,275,251
| +49,048% | +$18M | 1.55% | 11 |
|
|
2019
Q2 | $29K | Buy |
+2,600
| New | +$29K | ﹤0.01% | 1097 |
|